by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases
Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...
by McKesson Ventures | Jun 17, 2022 | Press Releases
McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and...
by McKesson Ventures | Feb 7, 2022 | Press Releases
Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...
by McKesson Ventures | Jan 25, 2022 | Press Releases
Technology-enabled service provider Reimagine Care is a leader in promoting support for oncologists by delivering valuable, home-centered cancer care. It recently announced that a $25 million capital raise has been completed. Led by LRVHealth, Santé Ventures, and...
by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News
RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...
